drugset / Trial / NCT01120327

A Pilot Study Exploring Efficacy and Safety of Amlodipine in the Stented Angina Patients

NCT01120327

Phase 4 Completed 211 enrolled Seoul National University Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

1. OBJECTIVES Primary objective to evaluate the difference of the peak oxygen uptake change (VO2 max, mL/kg/min) in amlodipine group against no CCB group at 9 months Secondary objectives To evaluate the change of sublingual nitrate use per day against no CCB group at 1 and 3 months To evaluate the change of biomarkers against no CCB group at 9 months 2. SUBJECTS AND CENTERS 212, stable angina patients with angiographically confirmed significant residual stenosis 10, 3rd-grade, teaching hospitals in Korea

Timeline

Start
2011-09
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified